Helsinki University Hospital Working Formulation

Performance index category

ECOG/WHO 0; Karnofsky 100-90 ECOG/WHO 1-2; Karnofsky 85-60 ECOG/WHO 3-4; Karnofsky <60

Largest diameter of largest metastasis (cm)

S-ALP or P-ALP, upper normal limit (U/l)

S-ALP or P-ALP (U/l)

S-ALP or P-ALP / upper normal limit

0.36

---

Results

The predicted median survival in patients with the current profile is 17.0 months

Helsinki University Hospital Working Formulation is stage IVa

Out of 100 cases with the current profile 50 are estimated to die of melanoma within 17.0 months from diagnosis